Showing 221-230 of 1381 results for "".
Blood Pressure Targets After Stroke: How Low Is Too Low?
https://practicalneurology.com/diseases-diagnoses/stroke/blood-pressure-targets-after-stroke-how-low-is-too-low/49161/Acute hypertensive response management after stroke is a dynamic process that requires careful integration of clinical trial evidence, pathophysiologic principles, imaging findings, and patient-specific factors.MS Minute: Cognitive Dysfunction in People Living with Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ms-minute-cognitive-dysfunction-in-people-living-with-multiple-sclerosis/32170/Cognitive deficits are common in people with multiple sclerosis and affect multiple domains, including employment, activities of daily living, and relationships.Vascular Cognitive Impairment
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/vascular-cognitive-impairment/30145/Targeting risk factors may decrease vascular cognitive impairments.Novel Lipid-Lowering Agents and Stroke Prevention:
New Tools, New Targetshttps://practicalneurology.com/diseases-diagnoses/stroke/novel-lipid-lowering-agents-and-stroke-preventionbrnew-tools-new-targets/32074/Established and novel lipid-lowering agents offer increasing opportunities to achieve effective primary and secondary stroke prevention.Clinical Use of Alzheimer Disease Biomarkers: Legal, Ethical, and Social Considerations
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/clinical-use-of-alzheimer-disease-biomarkers-legal-ethical-and-social-considerations/32141/Legal, ethical, and social considerations are emerging along with the clinical implementation of Alzheimer disease biomarkers.Stroke Snapshot: Cerebral Microinfarcts—Etiology and Clinical Implications of This Novel MRI Marker
https://practicalneurology.com/diseases-diagnoses/stroke/stroke-snapshot-cerebral-microinfarcts-etiology-and-clinical-implications-of-this-novel-mri-marker/32105/Cerebral microinfarcts—microscopic brain lesions of ischemic origin—have been linked to cerebral small vessel disease, microemboli, cerebral hypoperfusion, cognitive decline, and poor clinical outcome.Diagnosis and Management of Sleep Disorders in Individuals with Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/diagnosis-and-management-of-sleep-disorders-in-individuals-with-parkinson-disease/37652/Common sleep disorders affecting people with Parkinson disease can be difficult to diagnose and require targeted treatments to optimize health, symptom management, and quality of life in this population.Emerging Therapies for Progressive Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/emerging-therapies-for-progressive-multiple-sclerosis/30125/A number of agents with putative neuroprotective effects have shown promise in recent clinical trials.Management of Poststroke Mobility and Spasticity
https://practicalneurology.com/diseases-diagnoses/stroke/management-of-poststroke-mobility-and-spasticity/32187/Mobility and spasticity management tailored appropriately to the individual’s needs and abilities, as well as early rehabilitation, result in reduced disability levels and optimized outcomes after stroke.Telepresence in Neurology
https://practicalneurology.com/columns/practice-management/telepresence-in-neurology/30389/